SpeeDx Pty. Ltd. are among the recipients of the New South Wales Medical Devices Fund (MDF) 2017-2018, announced last night. SpeeDx was granted a second MDF award of A$2.5 million...
Strategic commercial partnership in key European markets with Cepheid. SYDNEY, AUSTRALIA--(Marketwired - Jun 8, 2017) - SpeeDx Pty, Ltd., a developer of innovative molecular diagnostic solutions, today announced an agreement with...
SpeeDx and Thermo Fisher Scientific Announce Strategic Partnership for FDA Clearance of Molecular Diagnostic. ResistancePlus™ MG Test would bring disease and antibiotic resistance testing to U.S. market for sexually transmitted infection...
A prospective evaluation study published in the Journal of Clinical Microbiology evaluated our ResistancePlus® MG assay against 1089 symptomatic and asymptomatic male and female urine and anogenital swab samples. Key Findings 6%...
The authors of the review, Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium, published in Nature Review Urology recommended that appropriate M. genitalium diagnostic testing become available on a routine...
This drug-resistant sexually transmitted infection is behaving like a superbug and researchers estimate as many as 400,000 Australians may be carrying it. You probably haven't heard of mycoplasma genitalium, or...
SpeeDx Pty. Ltd. announced the publication of a novel technology, ‘Superior Multiplexing Capacity of PlexPrimers Enables Sensitive and Specific Detection of SNPs and Clustered Mutations in qPCR’ in PLOS One...
Mycoplasma genitalium (MG) is one of the fastest growing STIs in the world and has been reported to have a higher incidence than gonorrhea. It has developed serious treatment challenges...
ResistancePlus® MG rapidly and reliably detects the disease and determines antibiotic resistance of this increasingly resistant sexually transmitted infection. SpeeDx Pty. Ltd. announced that the study, “Evaluation of a commercial multiplex...
Dr Jensen’s article highlights the problem facing us but provides a guide to potential solutions. Dr Jorgen Jensen has contributed an interesting article to the Guardian newspaper Antibiotic Resistance campaign, which...
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |